{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:02Z","timestamp":1786118642301,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/bor.0b013e32802bf79d","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T20:08:32Z","timestamp":1170446912000},"page":"101-105","source":"Crossref","is-referenced-by-count":26,"title":["Outcomes in rheumatoid arthritis: incorporating the patient perspective"],"prefix":"10.1097","volume":"19","author":[{"given":"Jenny E","family":"Heller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Shadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","first-page":"868","article-title":"Outcomes from the Patient Perspective Workshop at OMERACT 6","volume":"30","author":"Kirwan","year":"2003","journal-title":"J Rheumatol"},{"key":"R2-4-20210128","first-page":"880","article-title":"Rheumatology outcomes: the patient's perspective","volume":"30","author":"Carr","year":"2003","journal-title":"J Rheumatol"},{"key":"R3-4-20210128","first-page":"2246","article-title":"Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment","volume":"32","author":"Kirwan","year":"2005","journal-title":"J Rheumatol"},{"issue":"5 Suppl 39","key":"R4-4-20210128","first-page":"S163","article-title":"The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years","volume":"23","author":"Bruce","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R5-4-20210128","first-page":"877","article-title":"Patients and clinicians have different perspectives on outcomes in arthritis","volume":"30","author":"Hewlett","year":"2003","journal-title":"J Rheumatol"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/art.21450","article-title":"Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored","volume":"53","author":"Hewlett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/keh412","article-title":"Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients","volume":"44","author":"Ahlmen","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","article-title":"The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.21491","article-title":"The effectiveness of antitumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study","volume":"54","author":"Finckh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","article-title":"Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria","volume":"43","author":"Fransen","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R11-4-20210128","first-page":"1075","article-title":"Adalimumab for treating rheumatoid arthritis","volume":"33","author":"Navarro-Sarabia","year":"2006","journal-title":"J Rheumatol"},{"issue":"Suppl 3","key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1736","article-title":"Unmet needs in rheumatoid arthritis","volume":"7","author":"Moreland","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar1933","article-title":"Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low: results from RABBIT, the German biologics register","volume":"8","author":"Listing","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/art.20350","article-title":"The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis","volume":"50","author":"Welsing","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R15-4-20210128","first-page":"1232","article-title":"Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis","volume":"32","author":"Genovese","year":"2005","journal-title":"J Rheumatol"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/rheumatology\/36.2.225","article-title":"The relationship between synovitis and erosions in rheumatoid arthritis","volume":"36","author":"Kirwan","year":"1997","journal-title":"Br J Rheumatol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric antitumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.21678","article-title":"Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial","volume":"54","author":"Smolen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/art.21421","article-title":"Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial","volume":"52","author":"Wassenberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","article-title":"Association of anticyclic citrullinated peptide antibodies, anticitrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis","volume":"1050","author":"Greiner","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17402520500233510","article-title":"The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis","volume":"12","author":"Shovman","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","article-title":"Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome","volume":"45","author":"Quinn","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset","volume":"65","author":"Berglin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.20659","article-title":"Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anticyclic citrullinated peptide antibody","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 39","key":"R27-4-20210128","first-page":"S1","article-title":"Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care","volume":"23","author":"Pincus","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-124-8-199604150-00012","article-title":"Rheumatoid arthritis: treat now, not later!","volume":"124","author":"Weinblatt","year":"1996","journal-title":"Ann Int Med"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/CPP43209","article-title":"Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents","volume":"43","author":"Eichler","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1002\/art.21494","article-title":"The disease activity score is not suitable as the sole criterion for initiation and evaluation of antitumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes","volume":"52","author":"Wolfe","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 39","key":"R31-4-20210128","first-page":"S85","article-title":"Rheumatology function tests: quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases","volume":"23","author":"Pincus","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/keh707","article-title":"What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?","volume":"44","author":"Plant","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/rheumatology\/keh484","article-title":"The patient's perspective and rheumatoid arthritis disease activity indexes","volume":"44","author":"Leeb","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/02729890122062361","article-title":"Lack of congruence in the ratings of patients' health status by patients and their physicians","volume":"21","author":"Suarez-Almazor","year":"2001","journal-title":"Med Decis Making"},{"key":"R35-4-20210128","first-page":"675","article-title":"Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity","volume":"27","author":"Neville","year":"2000","journal-title":"J Rheumatol"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/art.20924","article-title":"Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis","volume":"53","author":"Eurenius","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.21865","article-title":"Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases","volume":"55","author":"Edwards","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/rheumatology\/kei114","article-title":"Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure","volume":"45","author":"Cross","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R39-4-20210128","first-page":"783","article-title":"Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology","volume":"23","author":"Bazzichi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/art.20694","article-title":"Are there more than cross-sectional relationships of social support and support networks with functional limitations and psychological distress in early rheumatoid arthritis? the European Research on Incapacitating Diseases and Social Support Longitudinal Study","volume":"51","author":"Demange","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R41-4-20210128","first-page":"1031","article-title":"Concordance between clinician and patient assessment of physical and mental health status","volume":"19","author":"Kwoh","year":"1992","journal-title":"J Rheumatol"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/03009740500343260","article-title":"Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive symptoms","volume":"35","author":"Rupp","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.20539","article-title":"Impact of fatigue on health-related quality of life in rheumatoid arthritis","volume":"51","author":"Rupp","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R44-4-20210128","first-page":"228","article-title":"Course of patient-reported health outcomes in rheumatoid arthritis: comparison of longitudinal and cross-sectional approaches","volume":"33","author":"Rupp","year":"2006","journal-title":"J Rheumatol"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","article-title":"Fatigue in rheumatoid arthritis reflects pain, not disease activity","volume":"45","author":"Pollard","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.21838","article-title":"Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis","volume":"55","author":"Moreland","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R47-4-20210128","first-page":"590","article-title":"Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis","volume":"32","author":"Strand","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32802bf79d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:24:24Z","timestamp":1786033464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200703000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32802bf79d","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}